Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

6.7.4. Growth hormone disorders

 

    Somatrogon This High-Cost Drug has been approved for the following indications: - Treatment of growth disturbance in children and young people aged 3 years and over as per NICE Guidance
For more information and NICE Guidance Click Here Somatrogon for treating growth disturbance in children and young people aged 3 years and over NICE Guidance TA863
  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •